聯合治療UTHR
那斯達克 · USD
494.63
-2.64
(-0.53%)
收盤 09/19 03:59 (UTC+8)
09/19 03:59 (UTC+8)
聯合治療UTHR
494.63
-2.64
(-0.53%)
財務數據
損益表
- 6.78
- 7.15
- 7.49
- 7.36
- 7.94
- 7.99
- 8.00
- 7.90
- 7.82
- 7.83
- 10.25
- 5.49
- 4.76
- -1.74
- 7.95
- 0.53
- 0.11
- -1.16
- -1.10
- 0.23
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 783,300 | 781,500 | 790,200 | 799,500 | 798,600 | 794,400 | 735,900 | 748,900 | 714,900 | 677,700 |
營業成本 | 99,500 | 133,400 | 103,400 | 100,900 | 87,600 | 92,500 | 75,900 | 83,100 | 77,800 | 72,900 |
營業毛利 | 683,800 | 648,100 | 686,800 | 698,600 | 711,000 | 701,900 | 660,000 | 665,800 | 637,100 | 604,800 |
營業費用 | 353,000 | 322,300 | 330,100 | 309,300 | 324,800 | - | - | - | - | 248,500 |
研發費用 | 146,300 | 138,200 | 139,500 | 127,500 | 134,000 | 149,000 | 133,800 | 103,500 | 139,600 | 104,100 |
推銷及管理費用 | 206,700 | 184,100 | 190,600 | 181,800 | 190,800 | 170,100 | 168,500 | 219,200 | 177,600 | 144,400 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 330,800 | 325,800 | 356,700 | 389,300 | 386,200 | 382,800 | 357,700 | 343,100 | 319,900 | 356,300 |
其他收入及費用 | 44,800 | -4,500 | 90,400 | - | - | 46,800 | 46,700 | 55,600 | 47,000 | 55,600 |
利息費用 | 2,900 | 3,000 | 3,100 | 3,000 | 7,300 | 6,100 | 7,900 | 10,100 | 11,600 | 13,300 |
稅前純益 | 372,700 | 318,300 | 444,000 | 438,000 | 408,400 | 423,500 | 396,500 | 388,600 | 355,300 | 398,600 |
所得稅 | 39,700 | 43,400 | 79,700 | 99,300 | 98,900 | 101,300 | 95,200 | 79,500 | 77,200 | 92,000 |
稅後純益 | 333,000 | 274,900 | 364,300 | 338,700 | 309,500 | 322,200 | 301,300 | 309,100 | 278,100 | 306,600 |
基本每股稅後盈餘(元) | 7.82 | 6.32 | 8.41 | 7.73 | 6.86 | 7.18 | 6.74 | 6.93 | 6.26 | 6.52 |
稀釋每股稅後盈餘(元) | 7.25 | 5.82 | 7.69 | 7.15 | 6.39 | 6.63 | 6.21 | 6.40 | 5.86 | 6.17 |
基本平均股數(千股) | 42600.00 | 43500.00 | 43300.00 | 43800.00 | 45100.00 | 44900.00 | 44700.00 | 44600.00 | 44400.00 | 47000.00 |
稀釋平均股數(千股) | 45800.00 | 47200.00 | 47300.00 | 47300.00 | 48300.00 | 48600.00 | 48700.00 | 48400.00 | 47500.00 | 49700.00 |
還原基本每股稅後盈餘(元) | 7.82 | 6.32 | 8.41 | 7.73 | 6.86 | 7.18 | 6.74 | 6.93 | 6.26 | 6.52 |
還原稀釋每股稅後盈餘(元) | 7.25 | 5.82 | 7.69 | 7.15 | 6.39 | 6.63 | 6.21 | 6.40 | 5.86 | 6.17 |
還原基本平均股數(千股) | 42,600 | 43,500 | 43,300 | 43,800 | 45,100 | 44,900 | 44,700 | 44,600 | 44,400 | 47,000 |
還原稀釋平均股數(千股) | 45,800 | 47,200 | 47,300 | 47,300 | 48,300 | 48,600 | 48,700 | 48,400 | 47,500 | 49,700 |
EBITDA(千元) | 399,800 | 343,900 | 469,900 | 462,900 | 436,800 | 449,400 | 424,100 | 417,800 | 385,600 | 426,900 |